XTrackers MSCI World Health Care UCITS ETF 1C
| Issuer: Xtrackers |
| Asset Class: Equity |
| TER: 25bps |
| Trading Currency: USD |
| Pays Income: False |
| Listing Date: 24 Mar 2016 |
| Ticker: XDWH |
| ISIN: IE00BM67HK77 |
This fund provides targeted exposure to the global healthcare sector, encompassing a wide range of companies from developed markets worldwide. By tracking a specific market index, it invests in leading firms across pharmaceuticals, biotechnology, medical technology, and healthcare services. This approach offers a diversified entry point into an industry that is fundamental to global well-being and economic activity. The portfolio is heavily weighted towards companies in the United States, reflecting the country's dominance in medical innovation and research, but also includes significant holdings in European and Japanese markets, providing broad geographical diversification within the developed world.
Investing in the healthcare sector presents a compelling dual opportunity, blending defensive qualities with long-term growth potential. Healthcare is often considered non-cyclical, as demand for medical products and services remains relatively stable regardless of economic conditions. Furthermore, the sector is supported by powerful secular tailwinds, including aging populations in many developed countries, rising global healthcare expenditure, and continuous advancements in medical treatments and technologies. These factors create a sustained demand for innovation and drive potential growth for companies at the forefront of the industry, from large-cap pharmaceutical giants to pioneering biotech firms.
This investment vehicle is suitable for those looking to add a strategic, sector-specific allocation to their portfolio. It allows for participation in the long-term structural growth trends of the healthcare industry while mitigating single-stock risk through diversification across more than 100 different companies. By focusing on established companies in developed economies, the fund targets a segment known for both stability and cutting-edge innovation. This makes it an attractive option for investors aiming to capitalize on the enduring importance and evolutionary nature of global health and medicine.
